Novartis reported $6.78B in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alcon AG ALC:SW USD 2.01B 23M
Almirall ALM:SM EUR 120.71M 706K
Amgen AMGN:US USD 4.76B 203M
Bayer BAYN:GR EUR 12.79B 1.42B
Biogen BIIB:US USD 1.38B 80.8M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Eli Lilly And LLY:US USD 3.83B 68.3M
Fresenius FRE:GR EUR 5B 302M
Galapagos GLPG:NA EUR 25.51M 1.5M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Hikma Pharmaceutical HIK:LN USD 765M 70M
Merck MRK:GR EUR 4.86B 386M
Novartis NOVN:VX USD 6.78B 101M
Orion ORNBV:FH EUR 309.1M 7.7M
Recordati REC:IM EUR 403.98M 5.81M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Roche Holding ROG:VX 8.29B 577M